151 related articles for article (PubMed ID: 10541382)
1. 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
O'Donnell RT; DeNardo GL; Kukis DL; Lamborn KR; Shen S; Yuan A; Goldstein DS; Mirick GR; DeNardo SJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3330s-3336s. PubMed ID: 10541382
[TBL] [Abstract][Full Text] [Related]
2. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
O'Donnell RT; DeNardo GL; Kukis DL; Lamborn KR; Shen S; Yuan A; Goldstein DS; Carr CE; Mirick GR; DeNardo SJ
J Nucl Med; 1999 Dec; 40(12):2014-20. PubMed ID: 10616879
[TBL] [Abstract][Full Text] [Related]
3. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
DeNardo GL; Kukis DL; Shen S; DeNardo DA; Meares CF; DeNardo SJ
Clin Cancer Res; 1999 Mar; 5(3):533-41. PubMed ID: 10100704
[TBL] [Abstract][Full Text] [Related]
4. Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.
Denardo GL; Denardo SJ; Kukis DL; O'Donnell RT; Shen S; Goldstein DS; Kroger LA; Salako Q; Denardo DA; Mirick GR; Mausner LF; Srivastava SC; Meares CF
Anticancer Res; 1998; 18(4B):2779-88. PubMed ID: 9713461
[TBL] [Abstract][Full Text] [Related]
5. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
DeNardo GL; O'Donnell RT; Shen S; Kroger LA; Yuan A; Meares CF; Kukis DL; DeNardo SJ
J Nucl Med; 2000 May; 41(5):952-8. PubMed ID: 10809213
[TBL] [Abstract][Full Text] [Related]
6. Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model.
Kroger LA; DeNardo SJ; DeNardo GL; Xiong CY; Winthrop MD; Gumerlock PH
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3010s-3014s. PubMed ID: 10541336
[TBL] [Abstract][Full Text] [Related]
7. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
DeNardo SJ; DeNardo GL; Kukis DL; Shen S; Kroger LA; DeNardo DA; Goldstein DS; Mirick GR; Salako Q; Mausner LF; Srivastava SC; Meares CF
J Nucl Med; 1999 Feb; 40(2):302-10. PubMed ID: 10025839
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
O'Donnell RT; Shen S; Denardo SJ; Wun T; Kukis DL; Goldstein DS; Denardo GL
Anticancer Res; 2000; 20(5C):3647-55. PubMed ID: 11268433
[TBL] [Abstract][Full Text] [Related]
10. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
DeNardo GL; DeNardo SJ; O'Donnell RT; Kroger LA; Kukis DL; Meares CF; Goldstein DS; Shen S
Clin Lymphoma; 2000 Sep; 1(2):118-26. PubMed ID: 11707820
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
DeNardo GL; Kukis DL; DeNardo SJ; Shen S; Mausner LF; O'Donnell RT; Lamborn KR; Meyers FJ; Srivastava SC; Miers LA
Cancer; 1997 Dec; 80(12 Suppl):2576-82. PubMed ID: 9406712
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to macrocycles in lymphoma.
DeNardo GL; Mirick GR; Kroger LA; O'Donnell RT; Meares CF; DeNardo SJ
J Nucl Med; 1996 Mar; 37(3):451-6. PubMed ID: 8772643
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).
DeNardo GL; Kukis DL; Shen S; Mausner LF; Meares CF; Srivastava SC; Miers LA; DeNardo SJ
Clin Cancer Res; 1997 Jan; 3(1):71-9. PubMed ID: 9815540
[TBL] [Abstract][Full Text] [Related]
14. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.
Mirick GR; O'Donnell RT; DeNardo SJ; Shen S; Meares CF; DeNardo GL
Nucl Med Biol; 1999 Oct; 26(7):841-5. PubMed ID: 10628566
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.
Kroger LA; DeNardo GL; Gumerlock PH; Xiong CY; Winthrop MD; Shi XB; Mack PC; Leshchinsky T; DeNardo SJ
Cancer Biother Radiopharm; 2001 Jun; 16(3):213-25. PubMed ID: 11471486
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.
Shen S; DeNardo GL; DeNardo SJ; Salako Q; Morris G; Banks D; Yuan A; DeNardo DA
J Nucl Med; 1996 Jan; 37(1):146-50. PubMed ID: 8543984
[TBL] [Abstract][Full Text] [Related]
17. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.
Deshpande SV; DeNardo SJ; Meares CF; McCall MJ; Adams GP; Moi MK; DeNardo GL
J Nucl Med; 1988 Feb; 29(2):217-25. PubMed ID: 3258025
[TBL] [Abstract][Full Text] [Related]
18. Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model.
Connett JM; Buettner TL; Anderson CJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3207s-3212s. PubMed ID: 10541365
[TBL] [Abstract][Full Text] [Related]
19. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.
DeNardo GL; DeNardo SJ; Goldstein DS; Kroger LA; Lamborn KR; Levy NB; McGahan JP; Salako Q; Shen S; Lewis JP
J Clin Oncol; 1998 Oct; 16(10):3246-56. PubMed ID: 9779698
[TBL] [Abstract][Full Text] [Related]
20. A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy.
Shen S; DeNardo GL; Jones TD; Wilder RB; O'Donnell RT; DeNardo SJ
J Nucl Med; 1998 Jul; 39(7):1223-9. PubMed ID: 9669399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
